AP NEWS

$9.41 Billion Wearable Injectors Market by Type & Therapy - Global Forecast to 2023 - ResearchAndMarkets.com

October 12, 2018

DUBLIN--(BUSINESS WIRE)--Oct 12, 2018--The “Wearable Injectors Market by Type (On-Body and Off-Body injectors (Infusion Pump Devices)), Therapy (Immuno-oncology, Diabetes, Cardiovascular Diseases, Parkinson’s Disease, Thalassemia, Primary Immunodeficiency Disease) - Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.

The global wearable injectors market is projected to reach USD 9.41 billion by 2023 from an estimated USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period.

The growing prevalence of targeted therapies, favorable reimbursement, and technological advancements in wearable injectors are expected to drive the growth of the wearable injectors market. However, the preference for alternative routes of drug delivery such as pens & autoinjectors is expected to restrain the growth of this market to a certain extent.

Based on type, the market is segmented into on-body and off-body injectors. The off-body injectors segment is expected to register the highest CAGR during the forecast period. The drawbacks associated with on-body wearable injectors, such as painful removal, skin sensitivity issues and irritation, and adhesive fitting issues have resulted in the increased demand for off-body injectors.

Based on therapy, the global wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (Parkinson’s Disease, thalassemia, and primary immunodeficiency disorders). The cardiovascular diseases segment is expected to witness the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the high burden of CVDs across the globe coupled with the growing availability of wearable injectors for the treatment of CVDs.

North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of chronic diseases in the US and Canada; favorable reimbursement scenarios; and an increasing number of awareness programs in the US and Canada.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Wearable Injectors Market Overview

6 Wearable Injectors Market By Type

7 Wearable Injectors Market By Therapy

8 Wearable Injectors Market By Region

9 Competitive Landscape

10 Company Profiles

Amgen Becton, Dickinson and Company Enable Injections Insulet Corporation Medtronic PLC Sensile Medical (A Part of Gerresheimer) Steadymed Therapeutics Tandem Diabetes Care, Inc. United Therapeutics Corporation Valeritas, Inc. Ypsomed

For more information about this report visit https://www.researchandmarkets.com/research/jtfc72/9_41_billion?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181012005296/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infusions and Injectables,Needles and Syringes

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES DIABETES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/12/2018 10:52 AM/DISC: 10/12/2018 10:52 AM

http://www.businesswire.com/news/home/20181012005296/en

AP RADIO
Update hourly